In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bio-logic wins two-year supply deal with University HealthSystem:

This article was originally published in Clinica

Executive Summary

Bio-logic Systems has been awarded a two-year, non-exclusive, single supplier distribution with University HealthSystem Consortium Services for its Traveler product line. The range is an ambulatory system for the testing and diagnosis of sleep disorders and epilepsy in the patient's home.

You may also be interested in...



Lupin Optimistic On Albuterol Given COVID-19 Demand

Lupin hopes a surge in demand for albuterol sulphate due to increased off-label use in COVID-19 patients will help its generic version, which is likely to be launched in the first half of FY21. But the Indian firm may recall a batch of metformin after the US FDA recently asked a few companies to retract extended-release versions due to NDMA concerns.

ASCO 2020: Pevonedistat Shows Promise In Higher-Risk MDS

Takeda is confident about the promise of its first-in-class molecule for higher-risk myelodysplastic syndromes after positive Phase II data.

QUOTED. 2 June 2020. Pamela Spence.

Medtech insiders offer 10 strategies for medtech companies to rethink their businesses. See what Ernst & Young’s global health sciences and wellness leader Pamela Spence said about it here.

Topics

UsernamePublicRestriction

Register

WI964856

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel